Annual Interest Expense
$1.85 M
+$1.36 M+280.04%
December 31, 2023
Summary
- As of February 22, 2025, VRDN annual interest expense is $1.85 million, with the most recent change of +$1.36 million (+280.04%) on December 31, 2023.
- During the last 3 years, VRDN annual interest expense has risen by +$1.34 million (+263.58%).
- VRDN annual interest expense is now -5.91% below its all-time high of $1.96 million, reached on December 31, 2013.
Performance
VRDN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$1.00 M
+$407.00 K+68.17%
September 30, 2024
Summary
- As of February 22, 2025, VRDN quarterly interest expense is $1.00 million, with the most recent change of +$407.00 thousand (+68.17%) on September 30, 2024.
- Over the past year, VRDN quarterly interest expense has increased by +$404.00 thousand (+67.33%).
- VRDN quarterly interest expense is now at all-time high.
Performance
VRDN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$3.10 M
+$404.00 K+14.96%
September 30, 2024
Summary
- As of February 22, 2025, VRDN TTM interest expense is $3.10 million, with the most recent change of +$404.00 thousand (+14.96%) on September 30, 2024.
- Over the past year, VRDN TTM interest expense has increased by +$2.00 million (+182.44%).
- VRDN TTM interest expense is now at all-time high.
Performance
VRDN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
VRDN Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +280.0% | +67.3% | +182.4% |
| 3 y3 years | +263.6% | +67.3% | +182.4% |
| 5 y5 years | +111.6% | +67.3% | +182.4% |
VRDN Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | -100.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | -100.0% | at high | >+9999.0% |
| alltime | all time | -5.9% | >+9999.0% | at high | -100.0% | at high | >+9999.0% |
Viridian Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.00 M(+68.2%) | $3.10 M(+15.0%) |
| Jun 2024 | - | $597.00 K(+1.7%) | $2.70 M(+19.0%) |
| Mar 2024 | - | $587.00 K(-35.9%) | $2.27 M(+22.8%) |
| Dec 2023 | $1.85 M(+280.0%) | $916.00 K(+52.7%) | $1.85 M(+68.1%) |
| Sep 2023 | - | $600.00 K(+261.4%) | $1.10 M(+65.8%) |
| Jun 2023 | - | $166.00 K(+0.6%) | $663.00 K(+1.8%) |
| Mar 2023 | - | $165.00 K(-1.8%) | $651.00 K(+34.0%) |
| Dec 2022 | $486.00 K(>+9900.0%) | $168.00 K(+2.4%) | $486.00 K(+51.4%) |
| Sep 2022 | - | $164.00 K(+6.5%) | $321.00 K(+104.5%) |
| Jun 2022 | - | $154.00 K(>+9900.0%) | $157.00 K(+5133.3%) |
| Mar 2022 | - | $0.00(-100.0%) | $3000.00(0.0%) |
| Dec 2021 | $3000.00(-99.4%) | $3000.00(>+9900.0%) | $3000.00(-98.3%) |
| Sep 2021 | - | $0.00(0.0%) | $180.00 K(-34.1%) |
| Jun 2021 | - | $0.00(-100.0%) | $273.00 K(-46.3%) |
| Dec 2020 | $508.00 K(-39.2%) | $180.00 K(+93.5%) | $508.00 K(+2.0%) |
| Sep 2020 | - | $93.00 K(-1.1%) | $498.00 K(-18.2%) |
| Jun 2020 | - | $94.00 K(-33.3%) | $609.00 K(-18.1%) |
| Mar 2020 | - | $141.00 K(-17.1%) | $744.00 K(-10.9%) |
| Dec 2019 | $835.00 K(-4.4%) | $170.00 K(-16.7%) | $835.00 K(-6.5%) |
| Sep 2019 | - | $204.00 K(-10.9%) | $893.00 K(-2.0%) |
| Jun 2019 | - | $229.00 K(-1.3%) | $911.00 K(+1.7%) |
| Mar 2019 | - | $232.00 K(+1.8%) | $896.00 K(+2.6%) |
| Dec 2018 | $873.00 K | $228.00 K(+2.7%) | $873.00 K(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $222.00 K(+3.7%) | $835.00 K(+24.4%) |
| Jun 2018 | - | $214.00 K(+2.4%) | $671.00 K(+28.8%) |
| Mar 2018 | - | $209.00 K(+10.0%) | $521.00 K(+36.0%) |
| Dec 2017 | $383.00 K(+303.2%) | $190.00 K(+227.6%) | $383.00 K(+74.9%) |
| Sep 2017 | - | $58.00 K(-9.4%) | $219.00 K(+19.0%) |
| Jun 2017 | - | $64.00 K(-9.9%) | $184.00 K(+28.7%) |
| Mar 2017 | - | $71.00 K(+173.1%) | $143.00 K(+50.5%) |
| Dec 2016 | $95.00 K(-32.6%) | $26.00 K(+13.0%) | $95.00 K(+3.3%) |
| Sep 2016 | - | $23.00 K(0.0%) | $92.00 K(-1.1%) |
| Jun 2016 | - | $23.00 K(0.0%) | $93.00 K(-34.5%) |
| Mar 2016 | - | $23.00 K(0.0%) | $142.00 K(+0.7%) |
| Dec 2015 | $141.00 K(-86.2%) | $23.00 K(-4.2%) | $141.00 K(+17.5%) |
| Sep 2015 | - | $24.00 K(-66.7%) | $120.00 K(+20.0%) |
| Jun 2015 | - | $72.00 K(+227.3%) | $100.00 K(-80.2%) |
| Mar 2015 | - | $22.00 K(+1000.0%) | $506.00 K(-50.5%) |
| Dec 2014 | $1.02 M(-47.9%) | $2000.00(-50.0%) | $1.02 M(-30.8%) |
| Sep 2014 | - | $4000.00(-99.2%) | $1.48 M(-27.6%) |
| Jun 2014 | - | $478.00 K(-11.3%) | $2.04 M(-0.1%) |
| Mar 2014 | - | $539.00 K(+17.7%) | $2.04 M(+4.1%) |
| Dec 2013 | $1.96 M(+23.4%) | $457.80 K(-19.4%) | $1.96 M(+30.4%) |
| Sep 2013 | - | $568.00 K(+18.5%) | $1.51 M(+60.6%) |
| Jun 2013 | - | $479.30 K(+4.7%) | $937.20 K(+104.7%) |
| Mar 2013 | - | $457.90 K | $457.90 K |
| Dec 2012 | $1.59 M | - | - |
FAQ
- What is Viridian Therapeutics annual interest expense?
- What is the all time high annual interest expense for Viridian Therapeutics?
- What is Viridian Therapeutics annual interest expense year-on-year change?
- What is Viridian Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly interest expense year-on-year change?
- What is Viridian Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Viridian Therapeutics?
- What is Viridian Therapeutics TTM interest expense year-on-year change?
What is Viridian Therapeutics annual interest expense?
The current annual interest expense of VRDN is $1.85 M
What is the all time high annual interest expense for Viridian Therapeutics?
Viridian Therapeutics all-time high annual interest expense is $1.96 M
What is Viridian Therapeutics annual interest expense year-on-year change?
Over the past year, VRDN annual interest expense has changed by +$1.36 M (+280.04%)
What is Viridian Therapeutics quarterly interest expense?
The current quarterly interest expense of VRDN is $1.00 M
What is the all time high quarterly interest expense for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly interest expense is $1.00 M
What is Viridian Therapeutics quarterly interest expense year-on-year change?
Over the past year, VRDN quarterly interest expense has changed by +$404.00 K (+67.33%)
What is Viridian Therapeutics TTM interest expense?
The current TTM interest expense of VRDN is $3.10 M
What is the all time high TTM interest expense for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM interest expense is $3.10 M
What is Viridian Therapeutics TTM interest expense year-on-year change?
Over the past year, VRDN TTM interest expense has changed by +$2.00 M (+182.44%)